Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Western Technology Investment (WTI) is a premier venture debt and investment firm that provides flexible financing solutions to high-growth technology and life science companies. Founded in 1980 and headquartered in Portola Valley, California, WTI is widely recognized as a pioneer in the venture debt industry, supporting startups from seed stage through late-stage growth. The firm has a significant track record in the healthcare sector, having provided critical capital to foundational biotechnology companies such as Amgen, Gilead Sciences, and Genentech. WTI's investment approach typically involves providing term loans and equipment financing, often accompanied by equity participation through warrants. Their deep expertise in the life sciences allows them to partner effectively with innovative companies developing therapeutics, medical devices, and diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Western Technology Seed Investment Fund.